Matthew R. Fusco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew R. Fusco has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Rohan Chitale
Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
9 shared publications - Michael T. Froehler
Cerebrovascular Program, Vanderbilt University Medical Center, Nashville, TN, USA
6 shared publications - Akshitkumar M. Mistry
University of Louisville 5 Louisville
4 shared publications - Eva A. Mistry
Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH
3 shared publications - Sanjana Salwi
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
3 shared publications - Jacob Jo
Vanderbilt Sports Concussion Center, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2 shared publications
Latest Publications
- Open Access
- 10 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Venous sinus stenting versus ventriculoperitoneal shunting: Comparing perioperative costs for idiopathic intracranial hypertension
Introduction: Venous sinus stenting (VSS) is an effective, less invasive alternative to ventriculoperitoneal shunting (VPS) for idiopathic intracranial hypertension (IIH). While efficacy is comparable, with some evidence favoring VSS for headache control, perioperative costs remain under-characterized due to reliance on reimbursement rates rather than actual expenditures. Objective: To compare the perioperative cost of elective VSS and VPS for IIH, including outpatient workup and follow-up costs, using detailed institutional cost data. Methods: We retrospectively analyzed IIH patients treated with VSS or VPS from 2017 to 2022 at a single center. All IIH-related costs were captured from 90 days pre-op through 90 days post-op and categorized as fixed (e.g. OR staff) or variable (e.g. supplies). Patients with fulminant IIH or unrelated elective procedures were excluded. Comparisons used Mann–Whitney U and Fisher's exact tests (p < 0.05). Results: Forty-three patients met criteria (VSS n = 19, VPS n = 24), with no significant differences in age, body mass index, papilledema, opening pressure, or pulsatile tinnitus. Preoperative costs were significantly higher for VSS (median $14,951 [IQR 10,835–16,043] vs $4767 [1, 293, 410–11]; p = 0.008), including both variable (p = 0.008) and fixed (p = 0.015) cost components. Surgical admission costs were similar between groups (p = 0.403), as were postoperative costs (p = 0.509). Total 180-day costs remained significantly higher for VSS ($38,576 [011–43, 36, 590]) compared to VPS ($31,509 [25, 208–37, 342]; p = 0.001). Conclusion: VSS incurs higher preoperative and total costs than VPS. Streamlining VSS workup may improve value. Further studies should assess downstream cost avoidance to determine long-term cost-effectiveness.
- 10 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Open AccessVenous sinus stenting versus ventriculoperitoneal shunting: Comparing perioperative costs for idiopathic intracranial hypertension
Introduction: Venous sinus stenting (VSS) is an effective, less invasive alternative to ventriculoperitoneal shunting (VPS) for idiopathic intracranial hypertension (IIH). While efficacy is comparable, with some evidence favoring VSS for headache control, perioperative costs remain under-characterized due to reliance on reimbursement rates rather than actual expenditures. Objective: To compare the perioperative cost of elective VSS and VPS for IIH, including outpatient workup and follow-up costs, using detailed institutional cost data. Methods: We retrospectively analyzed IIH patients treated with VSS or VPS from 2017 to 2022 at a single center. All IIH-related costs were captured from 90 days pre-op through 90 days post-op and categorized as fixed (e.g. OR staff) or variable (e.g. supplies). Patients with fulminant IIH or unrelated elective procedures were excluded. Comparisons used Mann–Whitney U and Fisher's exact tests (p < 0.05). Results: Forty-three patients met criteria (VSS n = 19, VPS n = 24), with no significant differences in age, body mass index, papilledema, opening pressure, or pulsatile tinnitus. Preoperative costs were significantly higher for VSS (median $14,951 [IQR 10,835–16,043] vs $4767 [1, 293, 410–11]; p = 0.008), including both variable (p = 0.008) and fixed (p = 0.015) cost components. Surgical admission costs were similar between groups (p = 0.403), as were postoperative costs (p = 0.509). Total 180-day costs remained significantly higher for VSS ($38,576 [011–43, 36, 590]) compared to VPS ($31,509 [25, 208–37, 342]; p = 0.001). Conclusion: VSS incurs higher preoperative and total costs than VPS. Streamlining VSS workup may improve value. Further studies should assess downstream cost avoidance to determine long-term cost-effectiveness.
- Open Access
- 2 July 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108387
The hidden cost of being uninsured: Stroke mortality after mechanical thrombectomy
- 2 July 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108387
Open AccessThe hidden cost of being uninsured: Stroke mortality after mechanical thrombectomy
- Open Access
- 16 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (7) , 669-670
The changing Food and Drug Administration landscape and what it means for neurointervention
- 16 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (7) , 669-670
Open AccessThe changing Food and Drug Administration landscape and what it means for neurointervention
- 24 February 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1793-1799
The Effect of Diagnostic Hypercapnic Cerebrovascular Reactivity Imaging on Vital Signs and Acute and Follow-Up Ischemic Adverse Events in Patients with Flow-Limiting Intracranial Arterial Stenosis
BACKGROUND AND PURPOSE: Anatomical imaging is a hallmark for visualizing chronic and acute infarcts but provides incomplete information on stroke risk. Respiratory hypercapnic gas challenges show promise for non-invasively assessing hemodynamic function and mapping cerebrovascular reserve capacity, an indicator of how near parenchyma is to exhausting autoregulatory capacity. However, limited safety information exists for this method in high-risk patients with flow-limiting stenosis. This study reports on the physiological changes and adverse events (AEs) following diagnostic hypercapnic cerebrovascular reactivity imaging assessments. MATERIALS AND METHODS: Between January 2011 and May 2024, reactivity scans were performed on 262 patients. In patients with flow-limiting intracranial arterial steno-occlusion (>70%), vital signs were assessed during a twice-repeated three-minute fixed-inspired 5%CO2/95%O2 stimulus, and acute (0–24 hours), sub-acute (24 hours – 2 months), and longer-term (2 – 12 months) AEs were recorded. RESULTS: 129 patients met criteria for flow-limiting arterial steno-occlusion. Blood pressure did not change (p>0.40) with hypercapnia. EtCO2 (baseline:36.5±4.5 mmHg, hypercapnia:42.5±3.8 mmHg) and SaO2 (baseline:97.5±1.8%, hypercapnia:99.4±0.8%) increased (p2 = end-tidal carbon dioxide, SaO2 = arterial oxygen saturation, BOLD = blood oxygenation level-dependent, AE = adverse event, SAE = serious adverse event
- 24 February 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1793-1799
The Effect of Diagnostic Hypercapnic Cerebrovascular Reactivity Imaging on Vital Signs and Acute and Follow-Up Ischemic Adverse Events in Patients with Flow-Limiting Intracranial Arterial Stenosis
BACKGROUND AND PURPOSE: Anatomical imaging is a hallmark for visualizing chronic and acute infarcts but provides incomplete information on stroke risk. Respiratory hypercapnic gas challenges show promise for non-invasively assessing hemodynamic function and mapping cerebrovascular reserve capacity, an indicator of how near parenchyma is to exhausting autoregulatory capacity. However, limited safety information exists for this method in high-risk patients with flow-limiting stenosis. This study reports on the physiological changes and adverse events (AEs) following diagnostic hypercapnic cerebrovascular reactivity imaging assessments. MATERIALS AND METHODS: Between January 2011 and May 2024, reactivity scans were performed on 262 patients. In patients with flow-limiting intracranial arterial steno-occlusion (>70%), vital signs were assessed during a twice-repeated three-minute fixed-inspired 5%CO2/95%O2 stimulus, and acute (0–24 hours), sub-acute (24 hours – 2 months), and longer-term (2 – 12 months) AEs were recorded. RESULTS: 129 patients met criteria for flow-limiting arterial steno-occlusion. Blood pressure did not change (p>0.40) with hypercapnia. EtCO2 (baseline:36.5±4.5 mmHg, hypercapnia:42.5±3.8 mmHg) and SaO2 (baseline:97.5±1.8%, hypercapnia:99.4±0.8%) increased (p2 = end-tidal carbon dioxide, SaO2 = arterial oxygen saturation, BOLD = blood oxygenation level-dependent, AE = adverse event, SAE = serious adverse event
- Open Access
- 12 February 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (3) , 219-220
Neuroendovascular robotics: wave of the future or failed promise?
- 12 February 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (3) , 219-220
Open AccessNeuroendovascular robotics: wave of the future or failed promise?
- Open Access
- 1 November 2023
- Published by Korean Society of Interventional Neuroradiology in Neurointervention
- Vol. 18 (3) , 172-181
Low Levels of Low-Density Lipoprotein Cholesterol Increase the Risk of Post-Thrombectomy Delayed Parenchymal Hematoma
Purpose: Low levels of low-density lipoprotein cholesterol (LDL-C) have been suggested to increase the risk of hemorrhagic transformation (HT) following acute ischemic stroke. However, the literature on the relationship between LDL-C levels and post-thrombectomy HT is sparse. The aim of our study is to investigate the association between LDL-C and delayed parenchymal hematoma (PH) that was not seen on immediate post-thrombectomy dual-energy computed tomography (DECT).Materials and Methods: A retrospective analysis was conducted on all patients with anterior circulation large vessel occlusion who underwent thrombectomy at a comprehensive stroke center from 2018–2021. Per institutional protocol, all patients received DECT immediately post-thrombectomy and magnetic resonance imaging or CT at 24 hours. The presence of immediate hemorrhage was assessed by DECT, while delayed PH was assessed by 24-hour imaging. Multivariable analysis was performed to identify predictors of delayed PH. Patients with hemorrhage on immediate post-thrombectomy DECT were excluded to select only those with delayed PH.Results: Of 159 patients without hemorrhage on immediate post-thrombectomy DECT, 18 (11%) developed delayed PH on 24-hour imaging. In multivariable analysis, LDL-C (odds ratio [OR], 0.76; P=0.038; 95% confidence interval [CI], 0.59–0.99; per 10 mg/dL increase) independently predicted delayed PH. High-density lipoprotein cholesterol, triglyceride, and statin use were not associated. After adjusting for potential confounders, LDL-C ≤50 mg/dL was associated with an increased risk of delayed PH (OR, 5.38; P=0.004; 95% CI, 1.70–17.04), while LDL-C >100 mg/dL was protective (OR, 0.26; P=0.041; 95% CI, 0.07–0.96).Conclusion: LDL-C ≤50 mg/dL independently predicted delayed PH following thrombectomy and LDL-C >100 mg/dL was protective, irrespective of statin. Thus, patients with low LDL-C levels may warrant vigilant monitoring and necessary interventions, such as blood pressure control or anticoagulation management, following thrombectomy even in the absence of hemorrhage on immediate post-thrombectomy DECT.
- 1 November 2023
- Published by Korean Society of Interventional Neuroradiology in Neurointervention
- Vol. 18 (3) , 172-181
Open AccessLow Levels of Low-Density Lipoprotein Cholesterol Increase the Risk of Post-Thrombectomy Delayed Parenchymal Hematoma
Purpose: Low levels of low-density lipoprotein cholesterol (LDL-C) have been suggested to increase the risk of hemorrhagic transformation (HT) following acute ischemic stroke. However, the literature on the relationship between LDL-C levels and post-thrombectomy HT is sparse. The aim of our study is to investigate the association between LDL-C and delayed parenchymal hematoma (PH) that was not seen on immediate post-thrombectomy dual-energy computed tomography (DECT).Materials and Methods: A retrospective analysis was conducted on all patients with anterior circulation large vessel occlusion who underwent thrombectomy at a comprehensive stroke center from 2018–2021. Per institutional protocol, all patients received DECT immediately post-thrombectomy and magnetic resonance imaging or CT at 24 hours. The presence of immediate hemorrhage was assessed by DECT, while delayed PH was assessed by 24-hour imaging. Multivariable analysis was performed to identify predictors of delayed PH. Patients with hemorrhage on immediate post-thrombectomy DECT were excluded to select only those with delayed PH.Results: Of 159 patients without hemorrhage on immediate post-thrombectomy DECT, 18 (11%) developed delayed PH on 24-hour imaging. In multivariable analysis, LDL-C (odds ratio [OR], 0.76; P=0.038; 95% confidence interval [CI], 0.59–0.99; per 10 mg/dL increase) independently predicted delayed PH. High-density lipoprotein cholesterol, triglyceride, and statin use were not associated. After adjusting for potential confounders, LDL-C ≤50 mg/dL was associated with an increased risk of delayed PH (OR, 5.38; P=0.004; 95% CI, 1.70–17.04), while LDL-C >100 mg/dL was protective (OR, 0.26; P=0.041; 95% CI, 0.07–0.96).Conclusion: LDL-C ≤50 mg/dL independently predicted delayed PH following thrombectomy and LDL-C >100 mg/dL was protective, irrespective of statin. Thus, patients with low LDL-C levels may warrant vigilant monitoring and necessary interventions, such as blood pressure control or anticoagulation management, following thrombectomy even in the absence of hemorrhage on immediate post-thrombectomy DECT.
- 29 June 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (8) , 107217
The clinical utility of dual-energy CT in post-thrombectomy care: Part 1, predictors and outcomes of subarachnoid and intraparenchymal hemorrhage
- 29 June 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (8) , 107217
The clinical utility of dual-energy CT in post-thrombectomy care: Part 1, predictors and outcomes of subarachnoid and intraparenchymal hemorrhage
- 1 April 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (4) , 105658
Creation and Validation of a Stroke Scale to Increase Utility of National Inpatient Sample Administrative Data for Clinical Stroke Research
- 1 April 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (4) , 105658
Creation and Validation of a Stroke Scale to Increase Utility of National Inpatient Sample Administrative Data for Clinical Stroke Research
- 1 February 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (2) , 105488
Neighborhood Socioeconomic Status and Mechanical Thrombectomy Outcomes
- 1 February 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (2) , 105488
Neighborhood Socioeconomic Status and Mechanical Thrombectomy Outcomes
- 24 November 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (2) , 105464
CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease
- 24 November 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (2) , 105464
CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease